Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

23. September 2022 16:30 ET | Quelle: Palisade Bio, Inc.

Palisade Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Carlsbad, CA, Sept. 23, 2022 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI), a clinical stage biopharmaceutical company advancing therapies for acute and chronic gastrointestinal (GI)...
13. Juli 2016 10:30 ET | Quelle: Cyrex Laboratories

Cyrex Array 2 Provides Canadian Clinicians Cutting-Edge Technology for Accurate Assessment and Monitoring of Intestinal Barrier Function

PHOENIX, AZ--(Marketwired - July 13, 2016) - Cyrex Laboratories, a clinical laboratory specializing in functional immunology and autoimmunity, offers Array 2, an intestinal antigenic permeability...
13. Juli 2016 10:00 ET | Quelle: Cyrex Laboratories

Cyrex Array 2 Provides Clinicians Cutting-Edge Technology for Accurate Assessment and Monitoring of Intestinal Barrier Function

PHOENIX, AZ--(Marketwired - July 13, 2016) - Cyrex Laboratories, a clinical laboratory specializing in functional immunology and autoimmunity, offers Array 2, an intestinal antigenic permeability...